Caris Life Sciences (CAI) Non Operating Income (2024 - 2026)

Caris Life Sciences' Non Operating Income history runs 3 years deep, the most recent figure standing at -$5.9 million for Q1 2026.

• On a quarterly basis, Non Operating Income rose 86.72% year-over-year to -$5.9 million in Q1 2026; TTM through Mar 2026 was -$74.5 million, a 47.25% decrease from a year earlier, with the FY2025 full-year figure at -$113.2 million, down 357.05% from the prior year.
• Non Operating Income climbed to -$5.9 million in Q1 2026 per CAI's latest filing, from -$6.5 million in the prior quarter.
• Across five years, Non Operating Income topped out at $825000.0 in Q2 2024 and bottomed at -$53.8 million in Q2 2025.
• The 3-year median for Non Operating Income is -$6.7 million (2024), against an average of -$15.6 million.
• Across the five-year window, Non Operating Income plunged 6621.33% in 2025 and surged 86.72% in 2026, its largest moves.
• Year by year, Non Operating Income stood at $99000.0 in 2024, then plunged by 6619.19% to -$6.5 million in 2025, then increased by 8.18% to -$5.9 million in 2026.
• Per Business Quant, the three latest CAI Non Operating Income figures stand at -$5.9 million (Q1 2026), -$6.5 million (Q4 2025), and -$8.3 million (Q3 2025).